SYNTHESIS AND RESOLUTION OF (+/-)-7-CHLORO-8-HYDROXY-1-(3'-IODOPHENYL)-3-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE (TISCH) - A HIGH-AFFINITY AND SELECTIVE IODINATED LIGAND FOR CNS D1 DOPAMINE RECEPTOR

被引:35
作者
CHUMPRADIT, S [1 ]
KUNG, MP [1 ]
BILLINGS, JJ [1 ]
KUNG, HF [1 ]
机构
[1] UNIV PENN,DEPT RADIOL,PHILADELPHIA,PA 19104
关键词
D O I
10.1021/jm00107a002
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and resolution of (+/-)-7-chloro-8-hydroxy-1-(3'-iodophenyl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, (+/-)-TISCH (8) has been achieved by resolution of intermediate 4, the O-methoxyl, 3'-bromo derivative, as the diastereomeric camphor sulfonate salt. The final products, R-(+)-8 and S-(-)-8, were prepared by treatment of R-(+)- or S-(-)-7, the 3'-tributyltin intermediates, with iodine in chloroform, followed by O-demethylation. By using HPLC with a chiral column, the optical purity (> 99%) of the intermediates and the final compounds was determined. Radioiodination was achieved by an iodo-destannylation reaction with sodium [I-125]iodide and hydrogen peroxide. As expected, the R-(+)-[I-125]-8 (the active isomer) displayed high affinity and selectivity to the CNS D-1 receptor in rat striatum tissue preparation (K(d) = 0.205 nM). The rank order of potency was as follows: SCH-23390 (1a) > (+/-)-8 > (+)-butaclamol > spiperone, WB4101 > dopamine, 5-HT. After an iv injection, the R-(+)-[I-125]-8 penetrated the blood-brain barrier with ease and displayed specific regional distribution corresponding to the D-1 receptor density, while the S-(-)-[I-125]-8 showed no specific uptake. The data suggest that the ligand may be useful as a pharmacological tool for characterizing the D-1 dopamine receptor. When labeled with I-123, this ligand is a potential agent for in vivo imaging of CNS D-1 dopamine receptor.
引用
收藏
页码:877 / 883
页数:7
相关论文
共 40 条
  • [11] COFFIN VL, 1989, J PHARMACOL EXP THER, V249, P769
  • [12] D-1 DOPAMINE-RECEPTORS IN THE RAT-BRAIN - AUTORADIOGRAPHIC LOCALIZATION USING [H-3]SCH 23390
    DAWSON, TM
    GEHLERT, DR
    YAMAMURA, HI
    BARNETT, A
    WAMSLEY, JK
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 108 (03) : 323 - 325
  • [13] EVALUATION OF POSITRON-EMITTING SCH-23390 ANALOGS AS TRACERS FOR CNS DOPAMINE D1 RECEPTORS
    DEJESUS, OT
    VANMOFFAERT, GJC
    FRIEDMAN, AM
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1989, 16 (01): : 47 - 50
  • [14] PET ANALYSIS OF HUMAN DOPAMINE RECEPTOR SUBTYPES USING C-11 SCH 23390 AND C-11 RACLOPRIDE
    FARDE, L
    HALLDIN, C
    STONEELANDER, S
    SEDVALL, G
    [J]. PSYCHOPHARMACOLOGY, 1987, 92 (03) : 278 - 284
  • [15] POSITRON TOMOGRAPHY OF A RADIO-BROMINATED ANALOG OF THE D1/DA1 ANTAGONIST, SCH-23390
    FRIEDMAN, AM
    DEJESUS, OT
    WOOLVERTON, WL
    VANMOFFAERT, G
    GOLDBERG, LI
    PRASAD, A
    BARNETT, A
    DINERSTEIN, RJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 108 (03) : 327 - 328
  • [16] SCH-23390 - THE 1ST SELECTIVE DOPAMINE D-1 ANTAGONIST
    HYTTEL, J
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 91 (01) : 153 - 154
  • [17] IORIO LC, 1983, J PHARMACOL EXP THER, V226, P462
  • [18] MULTIPLE RECEPTORS FOR DOPAMINE
    KEBABIAN, JW
    CALNE, DB
    [J]. NATURE, 1979, 277 (5692) : 93 - 96
  • [19] KUNG HF, 1988, NUCL MED BIOL, V15, P187
  • [20] KUNG HF, 1980, J NUCL MED, V21, P147